Knight Cancer Institute

Portland, Oregon 97239

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Metastatic Castration Resistant Prostate Cancer

Studies at this site

• A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. — Recruiting now
• A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed